Derma cosmetic, CELUQUE introduced Korean medical skin care products at the 3rd Aesthetic Medicine World Congress (AMWC) in Shenzhen, China, held from December 6th to 8th.

AMWC is the most prestigious conference in the field of anti-aging, with 120 countries participating, this time being the first in China. AMWC provides up-to-date cosmetic information, as well as new products from dermatologists and plastic surgeons and medical companies.

As attention has been drawn to the medical industry, CELUQUE was recently introduced to world-renowned societies and trade fairs such as the Hong Kong Cosmetics Beauty Expo.

CELUQUE, the founding member of Cell Fusion C, which has been planning and developing the first medical skin care brand to write aggressive marketing and trade export success to over 60 domestic hospitals, has been based on bio-innovation technology. By signing MOUs with 20 overseas countries, we plan to expand the infrastructure to promote exports such as contracts, customs, and permits.

CELUQUE is in the process of registering a Chinese trademark and obtaining a sanitary license for the Chinese market, targeting the global market, and establishing a branch in China.

Park Young-kwang, vice chairman of ABTIRONBIO said, “We are pleased to be recognized for the design and product capability of our products once again globally. We will target the global medical market. ”